Commonwealth Financial Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Commonwealth Financial Services's DGX Position: Q3 2026 in Review
Commonwealth Financial Services reduced its Quest Diagnostics (DGX) stake by 23% in Q3 2026, selling an estimated $83.9K and leaving 1,226 shares worth $286K. The position accounts for 0.05% of the portfolio, ranked #187.
Commonwealth Financial Services first reported a position in DGX in Q3 2023 and has held it in 13 quarters since. The position peaked at $388K in Q1 2026. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Commonwealth Financial Services held 1,226 shares of Quest Diagnostics worth $286K as of Q3 2026.
- Commonwealth Financial Services sold 363 Quest Diagnostics shares in Q3 2026, an estimated $83.9K.
- Quest Diagnostics made up 0.05% of Commonwealth Financial Services's portfolio in Q3 2026, its #187 holding.
- Commonwealth Financial Services first reported a position in Quest Diagnostics in Q3 2023 and has held it in 13 quarters since.
- Commonwealth Financial Services's Quest Diagnostics position peaked at $388K in Q1 2026.
- 266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Commonwealth Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.